PATENT CLAIM ANALYSIS

Application Number: 15771317
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["514", "171000"]

Abstract:
The present invention relates to a method and composition for use in treating a condition that benefits from the reduction of hepatic and/or visceral fat, such as polycystic ovary syndrome in adolescent girls or women of childbearing age, involving the use of spironolactone, pioglitazone and metformin.

Claim (Index 44):
A method for preventing or treating low ovulation rate associated with liver steatosis in adolescent girls or women of childbearing age said method comprising administering to an adolescent girl or woman of childbearing age the combined administration of spironolactone, pioglitazone and metformin.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.21951
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10317126', '15522599', '14535810', '14843873', '15119695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7090849229469695
- 35 USC 102 Novelty (BERT): 0.4947865123301252
- Combined Prediction Score: 0.687655081885285
- Mean Citation Score: 203.706706
- Max Citation Score: 229.1751
- Similarity Product: 165.6588305585503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test